Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2024-08-02 Regulatory Filings
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the conclusion of a US FDA un-announced inspection at the company's manufacturing facility. It mentions the inspection dates, the nature of observations (3 Form 483 observations), and the company's plan to submit corrective actions. The document is short (1588 characters) and serves as an announcement of regulatory inspection results rather than a detailed report or financial filing. It does not contain financial data, management discussion, or audit information. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about compliance and inspection outcomes.
2024-08-02 English
Copy of Newspaper Publication
AGM Information Classification · 90% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement published under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the publication of a notice for the 46th Annual General Meeting (AGM) scheduled on August 30, 2024. The document includes copies of the newspaper advertisements in English and Telugu. The content is an announcement about the AGM notice publication rather than the AGM materials themselves or the AGM meeting details. The document length is short (1933 characters), and it primarily serves as a notification of the publication of the AGM notice, not the AGM report or presentation. Therefore, it fits best under the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices. However, since this is specifically about the advertisement of the AGM notice, it is more aligned with AGM Information rather than a report publication announcement or regulatory filing. Confidence is high due to clear references to the AGM notice publication and Regulation 47 compliance.
2024-08-01 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the conclusion of a US FDA surprise inspection at the company's manufacturing facility. It mentions the inspection dates, observations made, and planned corrective actions. The content is an announcement of a regulatory inspection outcome rather than a financial report, management change, or other specific filings. The document length is short (1561 characters) and serves as a regulatory update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-25 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Gland Pharma has received tentative approval from the US FDA for a specific pharmaceutical product. It is addressed to stock exchanges and references regulatory compliance under SEBI Listing Obligations. The content focuses on the announcement of regulatory approval and product information, not on financial results, management changes, or detailed financial data. The document length is 4196 characters, which is relatively short and typical for an announcement rather than a full report. There is no indication of financial statements, audit information, or detailed management discussion. Therefore, this document fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-07-23 English
Board Meeting — GLAND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 06-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2024-07-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming Earnings Conference Call scheduled for August 6, 2024, to discuss the company's financial performance for the quarter ended June 30, 2024. It includes details about the call, dial-in information, and mentions that the transcript and audio recording will be made available on the company's website after the call. The document does not contain actual financial results or substantive financial data but is an announcement of the event where such results will be discussed. Therefore, it is not an Earnings Release (ER) or Call Transcript (CT) itself but an announcement about the Earnings Call. Given the document length is short (2494 characters) and it serves as an announcement, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such notifications that do not fit other specific categories.
2024-07-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.